- Home
- ITOS vs BGT Comparison
ITOS vs BGT Comparison
Compare ITOS & BGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- BGT
- Stock Information
- Founded
- ITOS 2011
- BGT 2004
- Country
- ITOS United States
- BGT United States
- Employees
- ITOS N/A
- BGT N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- BGT Trusts Except Educational Religious and Charitable
- Sector
- ITOS Health Care
- BGT Finance
- Exchange
- ITOS Nasdaq
- BGT Nasdaq
- Market Cap
- ITOS 270.7M
- BGT 300.3M
- IPO Year
- ITOS 2020
- BGT N/A
- Fundamental
- Price
- ITOS $6.51
- BGT $11.69
- Analyst Decision
- ITOS Strong Buy
- BGT
- Analyst Count
- ITOS 3
- BGT 0
- Target Price
- ITOS $26.00
- BGT N/A
- AVG Volume (30 Days)
- ITOS 413.2K
- BGT 107.2K
- Earning Date
- ITOS 05-09-2025
- BGT 01-01-0001
- Dividend Yield
- ITOS N/A
- BGT 10.77%
- EPS Growth
- ITOS N/A
- BGT N/A
- EPS
- ITOS N/A
- BGT N/A
- Revenue
- ITOS $35,000,000.00
- BGT N/A
- Revenue This Year
- ITOS N/A
- BGT N/A
- Revenue Next Year
- ITOS $31.74
- BGT N/A
- P/E Ratio
- ITOS N/A
- BGT N/A
- Revenue Growth
- ITOS 177.89
- BGT N/A
- 52 Week Low
- ITOS $4.80
- BGT $10.89
- 52 Week High
- ITOS $18.75
- BGT $13.42
- Technical
- Relative Strength Index (RSI)
- ITOS 55.62
- BGT 40.26
- Support Level
- ITOS $4.80
- BGT $11.64
- Resistance Level
- ITOS $5.55
- BGT $12.07
- Average True Range (ATR)
- ITOS 0.43
- BGT 0.38
- MACD
- ITOS 0.13
- BGT 0.00
- Stochastic Oscillator
- ITOS 97.16
- BGT 65.78
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About BGT BlackRock Floating Rate Income Trust
Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.